DEVANIB 6MG TAB

DEVANIB 6MG TAB contains deucravacitinib, a novel oral JAK inhibitor designed for targeted immune modulation. Each tablet delivers 6mg of the active ingredient, formulated for systemic absorption and consistent therapeutic effect.
Deucravacitinib works by selectively inhibiting JAK1 and TYK2 signaling pathways, making it suitable for inflammatory and autoimmune conditions where dysregulated immune response plays a key role. The oral formulation offers convenient daily dosing without the need for injections.
This medication is indicated for patients requiring potent immunomodulatory therapy with a favorable tolerability profile. DEVANIB is manufactured to pharmaceutical standards ensuring purity, stability, and bioavailability. Store in a cool, dry place away from direct sunlight.
Always take as prescribed by your healthcare provider. Individual response may vary based on condition severity and patient factors.